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Abstract     
A convenient synthesis in optically pure form of a derivative of L-proline is described, called 
PhotoProline, containing a diazirine group at position-4 of the pyrrolidine ring, starting from L-
4-hydroxyproline. The use of Fmoc-L-PhotoProline in the synthesis of a cyclic peptidomimetic 
antibiotic demonstrates that this photoprobe can be incorporated into synthetic peptides using 
solid-phase Fmoc chemistry. Photoproline may be of wide value in the preparation of diverse 
peptide-based photoaffinity probes. 
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Introduction    
 
Photoaffinity labelling is a powerful tool for identifying targets of biologically active small 
molecules.1 A key requisite is that a photolabile group can be incorporated into the small 
molecule, along with a probe to allow later detection of photo-crosslinked receptors, without 
appreciable loss of biological activity and specificity. One of the most versatile photolabile 
groups for this purpose is the diazirine, due to its small size, and efficient and irreversible 
formation of a reactive carbene upon excitation at 350 nm.2, 3 Amino acid-based photoaffinity 
probes, including the phenylalanine analogues p-benzoylphenylalanine, p-azidophenylalanine 
and 4-[3-trifluoromethyl]-3H-diazirin-3-yl]-phenylalanine have been known for some time,4-6 
and more recently the alkyldiazirine amino acid analogs Photo-Leucine,  and Photo-Methionine 
have been described.7, 8 Here we describe the synthesis and application of a related alkyldiazirine 
derivative of proline (PhotoProline), containing a diazirine group at position-4 of the pyrrolidine 
ring. A photolabile derivative of proline may be of special interest, since proline can have an 
important influence on peptide backbone conformation, and it frequently occurs within the 
energetically important epitopes in many biologically active peptides and proteins. 
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Results and Discussion    
The synthesis of Fmoc-protected L-photoproline (PhotoPro), starting from relatively inexpensive 
L-trans-4-hydroxyproline, is shown in Scheme-1. The method used to install the diazirine group 
finds precedence in earlier published routes to PhotoLeucine and PhotoMethionine.7, 8 The 
Fmoc-derivative was produced to allow incorporation of PhotoPro into synthetic peptides using 
standard solid-phase Fmoc chemistry. The enantiomer (Fmoc-D-PhotoPro) can be made in the 
same way, after epimerization of L-trans-4-hydroxyproline to D-cis-4-hydroxyproline, which is 
convenient to carry out on a mol scale following a published procedure.9 
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Scheme-1. Synthesis of Fmoc-L- and D-PhotoProline. 
 
We are interested in the application of PhotoPro to study the mechanism of action of a new 
family of peptidomimetic antibiotics active against the important human gram-negative pathogen 
Pseudomonas aeruginosa.10 The lead compound (L27-11, Figure-1) shows a minimal inhibitory 
concentration (MIC) against P. aeruginosa, including many multi-drug resistant clinical isolates, 
in the low nanomolar range.  
 
Figure-1. Peptidomimetic antibiotic L27-11. The D-Pro-L-Pro template is highlighted. 
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The cellular target of this peptidomimetic antibiotic was shown recently to be the ß-barrel outer 
membrane protein LptD, which is known to play a key role in outer membrane (OM) biogenesis 
by functioning with the lipoprotein LptE to transport lipopolysaccharide from the periplasm to 
the outer leaflet of the OM.11 Peptidomimetic L27-11 contains a D-Pro-L-Pro template, which is 
designed to stabilize ß-hairpin-like conformations in the macrocycle.12 We, therefore, set out to 
replace the L-Pro residue in L27-11 by L-PhotoPro, in order to first investigate the effect of this 
change upon antimicrobial activity. 
 
The synthetic approach to the L-PhotoPro analogue of L27-11 (Photo-L27-11) is shown in 
Scheme-2. The peptide synthesis was planned such that the PhotoPro could be incorporated close 
to the end of the solid-phase assembly process. However, we have subsequently used this amino 
acid for the synthesis of many other peptides, and so far no problems (e.g. instability) have been 
encountered with its use in Fmoc-solid-phase peptide synthesis. After assembly on the resin, the 
side-chain protected linear peptide chain was cleaved from the resin with mild acid, cyclized in 
dilute DMF solution, and the cyclic product was then deprotected with TFA. The final product 
was purified by reverse phase HPLC. 
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Scheme-2. Synthesis of Photo-L27-11. 
 
The antimicrobial activity of Photo-L27-11 against Pseudomonas aeruginosa ATCC 27853 was 
assayed using a standardized broth microdilution method. The MIC measured in Müller-Hinton 
broth was 0.008 µg/ml, which is essentially identical to that found for L27-11.10 Thus, the 
presence of the diazirine group has no effect on the potent antimicrobial activity of L27-11. We 
have also recently reported another analogue of this cyclic peptide, containing not only 
PhotoPro, but also with Thr replaced by a biotin tag (N-γ-(N-biotinyl-3-(2-(2-(3-
aminopropyloxy)-ethoxy)-ethoxy)-propyl)-L-glutamine (Glu(biotinyl-PEG, Novabiochem)).10 
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This photoprobe was used successfully in a photolabelling experiment to show that the 
peptidomimetic antibiotic binds to the OM protein LptD in P. aeruginosa. 
 
Photoproline is readily available using the synthetic method reported here, and so may be of 
wide value in the preparation of diverse peptide-based photoaffinity probes. 
 
 
Experimental Section     
 
N-Boc-L-trans-4-Hydroxyproline 
L-trans-4-Hydroxyproline (15 g, 114.4 mmol) was dissolved in water (60 ml) and dioxane (30 
ml). Boc2O (23.75 g, 109 mmol) and NaHCO3 (12.08 g, 144 mmol) were added at pH ~ 7-8. The 
reaction was stirred overnight at room temp. The solution was filtered and dioxane was removed 
in vacuo. Excess Boc2O was extracted into ice-cooled diethyl ether. The aqueous phase was 
acidified with 1 N HCl to pH 3. The product was extracted with ethyl acetate (4×) and the 
organic layers were combined, dried over Na2SO4, and the solvent removed in vacuo. The 
product was dried at high vacuum. Yield: 22.9 g (87%). m.p. 122-125oC. [α]20°C589nm = -79.4° (c 
= 9.9 mg/ml, H2O). IR: υ (cm1) = 1734 (s), 1662 (s). 1H-NMR (500 MHz, CDCl3): δ (ppm) = 
4.50-4.41 (m, 2H); 3.64-3.48 (m, 2H); 2.36-2.14 (m, 2H); 1.48-1.43 (d, 9H). 13C-NMR (DMSO-
d6): δ (ppm) = 174.29 + 173.78 (cis and trans rotamers), 153.64 + 153.10, 78.66, 68.39 + 67.69, 
57.57 + 57.33, 54.55 + 54.24, 38.60 + 37.86, 27.97 + 27.77. 
 
N-Boc-L-4-oxoproline 
N-Boc-L-4-hydroxyproline (5 g, 21.6 mmol) was dissolved in 400 ml acetone. Jones reagent (37 
ml, 98.8 mmol) was added drop-wise with cooling over 10 min and the reaction mixture was 
stirred for 2 h. Methanol (8.1 ml) was added drop-wise and the reaction mixture was then filtered 
through celite and concentrated in vacuo. EtOAc (270 ml) was added and the solution was again 
filtered through celite. The filtrate was washed with brine (6 × 100 ml). The organic phase was 
dried over Na2SO4 and solvent removed in vacuo. The product crystallized from ethyl acetate. 
Yield: 2.58 g (52.1%). m.p. 159-163°C (lit. 160-162°C).13 [α]20°C589nm = +19.7 (c = 31.6 mg/ml, 
acetone). IR: υ (cm1) = 1768 (s), 1751 (s), 1654 (s). 1H-NMR (500 MHz, acetone-d6): δ (ppm) 
4.76-4.73 (t, 1H); 3.9-3.7 (m, 2H); 3.18-3.08 (m, 1H); 2.59-2.56 (d, 1H); 1.46-1.44 (2 × s, 9H). 
13C-NMR (acetone-d6): δ (ppm) = 209.07 + 208.39; 173.74 + 173.49, 155.07 + 154.32, 80.84, 
57.14 + 56.51, 53.39 + 52.99, 41.73 + 41.19, 28.44 + 28.35. ESI-MS: m/z 228.0 (M-H+). 
 
N-Boc-L-4-diazirinylproline 
N-Boc-L-4-oxoproline (3.08 g, 13.5 mmol) was charged into a three necked-flask (100 ml) and 
ammonia was slowly condensed into the flask. The solution was refluxed for 5 h with stirring. 
The solution was cooled with a dry-ice bath and a solution of hydroxylamine-O-sulfonic acid in 
anhydrous methanol (8 ml, 1.84 M, 14.7 mmol) was added. The mixture was refluxed for a 
further 1.5 h. Anhydrous methanol (18 ml) was added while the reaction was cooled with a dry-
ice bath. The solution was stirred overnight to allow the ammonia to evaporate. The resulting 
slurry was filtered through a sintered glass-funnel and the filter cake was washed twice with 
methanol (50 ml). The combined methanol phases were treated with triethylamine (1.88 ml, 13.6 
mmol) and concentrated to ∼15 ml. Another equivalent of triethylamine (1.88 ml, 13.6 mmol) 
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was added, the solution was cooled with an ice bath and titrated with a solution of I2 in MeOH 
(0.1 M) until the solution remained a brown colour. The solvent was removed in vacuo and the 
resulting slurry was dissolved in water (50 ml). The solution was acidified to pH 2 and the 
product was extracted with ethyl acetate (4 × 50 ml). The organic phase was washed once with 
brine and dried over Na2SO4. The solvent was removed in vacuo and product was purified by 
flash silica chromatography (95-5, CH2Cl2-MeOH). Yield: 0.99 g (31%). m.p. 104-107°C. 
[α]20°C589nm = +16.0° (c = 10.1 mg/ml, MeOH). IR: υ (cm1) = 1742 (s), 1636 (s), 1579 (w)14. 1H-
NMR (600 MHz, CDCl3): δ (ppm) = 4.66-4.54 (2 × d × d, J=9.8 Hz & J=2.2 Hz, 1H); 3.24-3.20 
(m, 1H); 3.20-3.06 (2 × d, J=12.6 Hz, 1H); 2.41-2.32 (m, 1H); 1.72-1.62 (2 × d × d, J=15.2 Hz & 
J=2.2 Hz, 1H); 1.46-1.44 (2 × s, 9H). 13C-NMR (CDCl3): δ (ppm) = 177.63 + 175.90; 154.66 + 
153.28; 81.89 + 81.44; 57.73 + 57.48; 48.40 + 48.03; 33.42 + 32.19; 30.80 + 30.30; 28.24 + 
28.14. HR-ESI-MS: m/z (M-H+) 240.0993 (mcalc. = 240.0990). 
 
N-Fmoc-L-4-diazirinylproline 
N-Boc-L-4-diazirinylproline (0.99 g, 4.11 mmol) was dissolved in dioxane (20 ml) and 
concentrated HCl (2 ml) was added dropwise. The reaction was stirred for 1.5 h and the solvent 
evaporated in vacuo. The sample was dissolved in water and lyophilized to remove excess acid. 
The residue was dissolved in aq. Na2CO3 (9% w/v, 17.5 ml) and 0.9 eq. Fmoc-O-N-
hydroxysuccinimide (1.24 g) in DMF/dioxane was added. The reaction was vortexed for 10 min 
and then water (150 ml) was added and unreacted Fmoc-O-N-hydroxysuccinimide was extracted 
with diethyl ether and EtOAc. The aqueous phase was acidified to pH 2 and the product was 
extracted with EtOAc (5 × 50 ml). The organic phase was dried with Na2SO4 and the solvent 
evaporated. The product was purified by flash chromatography first with silica using 94-5-1 
CH2Cl2-MeOH-AcOH, and then using 90-10-0.25, EtOAc-n-hexane-AcOH as eluant. A white 
powder was obtained after lyophilization. Yield: 672 mg (46%). m.p. 113-116°C. [α]20°C589nm = 
+15.3° (c = 10.3 mg/ml, MeOH). IR: υ (cm1) = 1736 (s), 1709 (s), 1669 (s), 1580 (w). 1H-NMR 
(500 MHz, CDCl3): δ (ppm) = 7.76-7.72 (m, 2H); 7.55-7.53 (m, 2H); 7.41-7.29 (m, 4H); 4.73-
4.70 (m, 1H); 4.56-4.41 (m, 2H); 4.26-4.18 (2 × t, J=6.8 Hz, 1H); 3.32-3.23 (d × d, J=21.3 & 
J=12.7 Hz, 1H); 3.14-3.12 (d, J=12.3 Hz, 1H); 2.43-2.32 (m, 1H); 1.72-1.55 (2 × d × d, J=15.0 
Hz & J=2.4 Hz, 1H). 13C-NMR (CDCl3): δ (ppm) = 176.30 + 175.53, 154.99 + 153.79, 143.57 + 
143.47, 141.35 + 141.32, 127.90 + 127.88, 127.17, 124.96 + 124.91, 120.10 + 120.05, 68.21 + 
67.68, 57.88 + 57.35, 48.36 + 48.16, 47.09 + 47.06, 33.59 + 32.31, 30.75 + 30.12. HR-ESI-MS: 
m/z (M-H+) 362.1149 (mcalc. = 362.1146). 
 
N-Fmoc-D-4-diazirinylproline 
The methods used to prepare this compound were identical to those described above for the L-
isomer, starting from D-cis-4-hydroxyproline.9 The product shows m.p. 113-116°C. [α]20°C589nm 
= -15.6° (c = 25.4 mg/ml, MeOH). IR: υ (cm1) = 1747 (s), 1710 (s), 1677 (s), 1580 (w). 1H-NMR 
(500 MHz, CDCl3): δ (ppm) = 7.78-7.69 (m, 2H); 7.56-7.51 (m, 2H); 7.43-7.26 (m, 4H); 4.76-
4.39 (m, 3H); 4.28-4.15 (2 × t, J=6.4 Hz, 1H); 3.34-3.21 (d × d, J=23.1 Hz & J=12.6 Hz, 1H); 
3.16-3.10 (d, J=12.6 Hz, 1H); 2.45-2.33 (m, 1H); 1.74-1.52 (2 × d × d, J=15.0 & J=2.3 Hz, 1H). 
13C-NMR (500 MHz, CDCl3): δ (ppm) = 176.71 + 176.03, 154.92 + 153.84, 143.59 + 143.48, 
141.34 + 141.31, 127.89 + 127.87, 127.17, 124.98 + 124.93, 120.09 + 120.05, 68.19 + 67.73, 
57.90 + 57.41, 48.36 + 48.16, 47.08 + 47.06, 33.59 + 32.40, 30.77 + 30.12. HR-ESI-MS: m/z 
(M+Na+) 386.1113 (mcalc. = 386.1111). 
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